Is Tatva Chintan Pharma Chem stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Tatva Chintan Pharma Chem pays dividends. Last time was Sunday 20th of October 2024 where the investors holding the stock on Friday 6th of September 2024 were paid INR2 per share. Over the last 3 times between 2022 and 2024, Tatva Chintan Pharma Chem has paid INR6 with an average of INR2 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Tatva Chintan Pharma Chem 10 years ago, but if you had invested on Thursday 29th of July 2021 when the price was INR2 312.20, you would have made a loss of INR-1 339.25 per share or -57.92%
Yes, the average daily trading liquidity for Tatva Chintan Pharma Chem is INR55 476 thousand. You should therefore be able to get in and out of your positions relatively fast.
Tatva Chintan Pharma Chem has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 2.71, the company's ability to pay off the debt is good. Tatva Chintan Pharma Chem has a good net profit margin of 7.71% and should have high tolerances against inflation.
We have calculated the inflation risk for Tatva Chintan Pharma Chem to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.